Shandong Buchang Pharmaceuticals Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002FV6
CNY
16.91
-0.05 (-0.29%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
10,846.78
13,029.77
14,719.19
15,535.78
15,772.16
14,033.03
13,389.59
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
10,846.78
13,029.77
14,719.19
15,535.78
15,772.16
14,033.03
13,389.59
Raw Material Cost
4,750.49
4,542.32
4,578.87
4,483.52
4,062.60
2,662.47
2,633.15
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
854.32
899.37
853.49
824.67
737.98
661.33
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
135.68
112.60
142.11
167.29
145.05
136.78
91.62
Selling and Distribution Expenses
5,002.07
7,075.03
8,076.52
8,929.08
8,914.59
8,608.16
8,487.45
Other Expenses
-65.87
-69.38
-73.05
-60.12
-37.24
-31.66
35.47
Total Expenditure (Excl Depreciation)
10,083.83
11,935.57
12,920.47
13,803.39
13,487.79
11,752.12
11,566.95
Operating Profit (PBDIT) excl Other Income
762.9000000000001
1094.2
1798.7
1732.4
2284.4
2280.9
1822.6
Other Income
-29.76
104.54
62.04
206.44
206.95
211.02
454.37
Operating Profit (PBDIT)
1,267.46
1,754.73
2,362.39
2,450.61
2,920.40
2,881.88
2,653.18
Interest
135.68
112.60
142.11
167.29
145.05
136.78
91.62
Exceptional Items
-898.65
-658.51
-2,972.92
-70.17
-0.36
0.00
0.00
Gross Profit (PBDT)
6,096.29
8,487.45
10,140.32
11,052.26
11,709.56
11,370.57
10,756.44
Depreciation
613.29
599.36
505.63
512.05
426.58
389.15
376.16
Profit Before Tax
-380.16
384.26
-1,258.27
1,701.10
2,348.40
2,355.95
2,185.39
Tax
337.10
242.69
331.59
478.29
517.55
451.48
347.11
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-553.80
318.97
-1,529.74
1,289.25
1,860.89
1,946.00
1,888.41
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-553.80
318.97
-1,529.74
1,289.25
1,860.89
1,946.00
1,888.41
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-148.60
-167.11
-61.24
-53.84
-17.75
17.23
19.09
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-702.39
151.87
-1,590.98
1,235.41
1,843.14
1,963.23
1,907.49
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
10,216.46
11,616.99
12,362.63
14,424.85
13,690.83
13,638.32
13,734.53
Earnings per share (EPS)
-0.51
0.29
-1.38
1.17
1.68
1.74
1.64
Diluted Earnings per share
-0.51
0.29
-1.38
1.17
1.68
1.74
1.64
Operating Profit Margin (Excl OI)
6.31%
8.06%
12.19%
11.15%
14.5%
16.26%
13.61%
Gross Profit Margin
2.15%
7.55%
-5.11%
14.25%
17.59%
19.56%
19.13%
PAT Margin
-5.11%
2.45%
-10.39%
8.3%
11.8%
13.87%
14.1%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -16.75% vs -11.48% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -562.41% vs 109.55% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -21.39% vs -28.26% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 20.52% vs -20.76% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Shandong Buchang Pharmaceuticals Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
10,846.78
0
10,846.78
Other Operating Income
0.00
0.00
0.00
Total Operating income
10,846.78
0
10,846.78
Raw Material Cost
4,750.49
0
4,750.49
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
854.32
0
854.32
Power Cost
0
0
0.00
Manufacturing Expenses
135.68
0
135.68
Selling and Distribution Expenses
5,002.07
0
5,002.07
Other Expenses
-65.87
0.00
-65.87
Total Expenditure (Excl Depreciation)
10,083.83
0
10,083.83
Operating Profit (PBDIT) excl Other Income
762.95
0.00
762.95
Other Income
-29.76
0
-29.76
Operating Profit (PBDIT)
1,267.46
0
1,267.46
Interest
135.68
0
135.68
Exceptional Items
-898.65
0
-898.65
Gross Profit (PBDT)
6,096.29
0
6,096.29
Depreciation
613.29
0
613.29
Profit Before Tax
-380.16
0
-380.16
Tax
337.10
0
337.10
Provisions and contingencies
0
0
0.00
Profit After Tax
-553.80
0
-553.80
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-553.80
0
-553.80
Share in Profit of Associates
0
0
0.00
Minority Interest
-148.60
0
-148.60
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-702.39
0
-702.39
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
10,216.46
0
10,216.46
Earnings per share (EPS)
-0.51
0
-0.51
Diluted Earnings per share
-0.51
0
-0.51
Operating Profit Margin (Excl OI)
6.31%
0%
0.00
6.31%
Gross Profit Margin
2.15%
0%
0.00
2.15%
PAT Margin
-5.11%
0%
0.00
-5.11%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 1,084.68 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -16.75% vs -11.48% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit -70.24 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -562.41% vs 109.55% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 129.72 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -21.39% vs -28.26% in Dec 2023

Annual - Interest
Interest 13.57 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 20.52% vs -20.76% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.31%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023